In Cohort 9 (400 mg AZD2811 on Day 1 every 21 days), DLTs were reported in 2 of 6 evaluable patients (grade 3 stomatitis in 1 patient and grade 4 decreased neutrophil count in 1 patient, requiring treatment with G-CSF). This evidence concerns the gene CSF3 and stomatitis.